Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,425,468
+$31,145,405 QoQ
Shares Held
2,695,108
+39.1% QoQ
Ownership
1.23%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#24
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. RLAY ranks #47 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,425,468 | 2,695,108 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,280,063 | 1,937,695 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $8,806,425 | 1,040,949 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,242,297 | 1,195,843 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,567,647 | 1,320,130 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,452,599 | 554,428 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,884,048 | 457,294 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $8,859,366 | 1,251,323 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,186,540 | 795,482 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,156,133 | 741,703 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,437,210 | 312,190 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,223,214 | 264,354 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,757,173 | 378,756 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,308,620 | 625,903 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,296,064 | 354,489 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $3,400,821 | 152,026 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,032,795 | 121,361 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,538,631 | 84,819 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,703,051 | 153,144 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,144,853 | 36,310 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,242,819 | 61,296 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,352,758 | 39,131 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $350,724 | 8,439 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $52,598 | 1,235 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||